Travere Therapeutics ( (TVTX) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Travere Therapeutics’ share price has been climbing as investors respond to upbeat analyst sentiment and growing optimism around the company’s outlook, even in a tough healthcare market. Analysts have reiterated their Buy recommendations on the stock, and the latest price targets still point to meaningful upside from current levels, reinforcing the bullish case for Travere among market watchers.
More about Travere Therapeutics
YTD Price Performance: 81.92%
Average Trading Volume: 1,839,782
Technical Sentiment Signal: Buy
Current Market Cap: $3.09B
For further insights into TVTX stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.